Home
About
FAQ
History (8)
Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization.
Modification of the effect of glycemic status on aortic distensibility by age in the multi-ethnic study of atherosclerosis.
Prostate cancer risk associated loci in African Americans.
Estimated power to detect linkage in three CM/DN data sets.
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
Shapiro MD, Fazio S. Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering. Nat Rev Cardiol. 2017 06; 14(6):319-320.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Anticholesteremic Agents
Cardiovascular Diseases
Cholesterol, LDL
Clinical Trials as Topic
Dyslipidemias
Humans
Pharmacogenetics
authors with profiles
Michael D. Shapiro DO, MCR